| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.0034 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.00095 | 1 |